Biomedical Prevention Focus Of 2015 Retrovirus Conference

By | AIDS Action Committee, Fenway Health Newsroom, HIV Prevention, HIV/AIDS | No Comments
The 2015 Conference on Retroviruses and Opportunistic Infections was recently held in Seattle. This conference, often called CROI for short, is one of the biggest annual scientific meetings on HIV/AIDS, opportunistic illnesses, and the health consequences of living with HIV. Biomedical prevention – in particular, PrEP – was a major focus of this year’s conference. Two European PrEP studies garnered a lot of attention due to their success in significantly reducing rates of HIV transmission. Check out the IPERGAY study to learn more about the efficacy of PrEP on-demand and the PROUD study to learn more about PrEP’s effectiveness among 
Read More

Why I Walk: Bette Byrnes, John’s Team

By | AIDS Action Committee, AIDS Walk & 5K Run Boston, Fenway Health Newsroom, HIV/AIDS | One Comment
If you ask Bette Byrnes, a longtime AIDS Walk Boston and 5K Run supporter, why she still makes the trip from Florida to Boston every June, she doesn’t have to think about her answer: it’s about home and family. “I’m from Boston originally – that’s still home,” she said. “And no matter what, I don’t want anyone to ever forget that AIDS took my son from me. In his memory, I will always walk as long as I can.” Bette’s first AIDS Walk Boston was in 1991 – the same year that her son, John, was diagnosed with the virus. 
Read More
Massachusetts Statehouse

HIV/AIDS and Hepatitis C Funding Cut in Governor’s FY2016 Budget Proposal

By | Fenway Health Newsroom, HIV/AIDS | No Comments
Facing an enormous shortfall of over $1 billion in next year’s budget, Governor Baker released his proposal for fiscal year 2016 cutting $2.3 million in HIV/AIDS and hepatitis C funding. These reductions are concerning and could threaten the high quality, life-saving care that Fenway Health and other organizations provide to thousands of people living with HIV/AIDS and hepatitis C Virus infection  in the Commonwealth. Continued investment in HIV/AIDS prevention and care is critical to reducing the spread of the virus and optimizing health outcomes for people living with the disease. Over the last decade, persistent efforts to get people tested 
Read More

Fenway’s Dr. Kenneth Mayer Appointed To PEPFAR Scientific Advisory Board

By | Fenway Health Newsroom, Fenway News, HIV/AIDS | No Comments
Dr. Kenneth Mayer, Co-Chair and Medical Research Director of The Fenway Institute, has been appointed to the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) Scientific Advisory Board (SAB). PEPFAR is a U.S. government-led initiative to save the lives of those living with HIV/AIDS across the globe, as well as the cornerstone of the U.S. President’s Global Health Initiative. As the largest international program of its kind, PEPFAR relies on the shared responsibility among donor and partner nations, and all those working in HIV/AIDS public health, to invest their time, money, and expertise in saving lives. Kenneth H. Mayer, MD, 
Read More

Fenway Institute To Serve As Testing Site For Innovative HIV Vaccine Studies

By | Fenway Health Newsroom, HIV/AIDS, HIV/AIDS, The Fenway Institute, Uncategorized | No Comments
Since the 1980s, Fenway Health has been a leader in HIV/AIDS prevention research and education. In that tradition, The Fenway Institute will soon serve as a site for two upcoming vaccine studies that have the potential to significantly reduce the number of new HIV infections: HVTN 106 and HVTN 110. HVTN 106 The first study, HVTN 106, will test four experimental vaccines against HIV by using DNA “primes” – DNA that can replicate the proteins found in HIV. The study vaccines are called DNA Nat-B env, DNA CON-S env, DNA Mosaic env, and MVA-CMDR. It’s important to note that the  
Read More